Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_assertion type Assertion NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_head.
- NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_assertion description "[Our findings suggest that deregulated AZGP1, PIP, S100A8 and UBE2C are critical for the aggressive breast cancer phenotype, which may be useful as novel therapeutic targets for drug development to complement established clinical variables.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_provenance.
- NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_assertion evidence source_evidence_literature NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_provenance.
- NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_assertion SIO_000772 24114735 NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_provenance.
- NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_assertion wasDerivedFrom befree-20150227 NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_provenance.
- NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_assertion wasGeneratedBy ECO_0000203 NP626154.RA_M8xmZbI3evbUx0PIdDSMNUNaJXBC0dCJ5ptZF4k3mQ130_provenance.